Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

unknown1
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown133%
recruiting133%
not_yet_recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors

NCT07759960
not_yet_recruitingnot_applicable

Endoscopic Resection for Small Rectal Neuroendocrine Tumors

NCT05429216
unknownnot_applicable

Endoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm

NCT03982264

Clinical Trials (3)

Showing 3 of 3 trials
NCT07759960Not Applicable

Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors

Recruiting
NCT05429216Not Applicable

Endoscopic Resection for Small Rectal Neuroendocrine Tumors

Not Yet Recruiting
NCT03982264Not Applicable

Endoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3